<?xml version="1.0" encoding="UTF-8"?>
<p>Now, at least one clinical trial has been conducted to investigate the efficacy and safety of thalidomide as an adjuvant therapy for COVID-19 pneumonia.
 <sup>
  <xref rid="bibr29-1759720X20947296" ref-type="bibr">29</xref>
 </sup>
</p>
